Found: 2
Select item for more details and to access through your institution.
Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00430-0
- By:
- Publication type:
- Article
Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors.
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 780, doi. 10.1159/000517490
- By:
- Publication type:
- Article